These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 32410646)

  • 1. Promotion of ubiquitination-dependent survivin destruction contributes to xanthohumol-mediated tumor suppression and overcomes radioresistance in human oral squamous cell carcinoma.
    Li M; Gao F; Yu X; Zhao Q; Zhou L; Liu W; Li W
    J Exp Clin Cancer Res; 2020 May; 39(1):88. PubMed ID: 32410646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin.
    Zhou Z; Han S; Liao J; Wang R; Yu X; Li M
    Am J Chin Med; 2023; 51(8):2221-2241. PubMed ID: 37930332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Aurora B kinase with Tanshinone IIA suppresses tumor growth and overcomes radioresistance.
    Li M; Liu H; Zhao Q; Han S; Zhou L; Liu W; Li W; Gao F
    Cell Death Dis; 2021 Feb; 12(2):152. PubMed ID: 33542222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tanshinone IIA inhibits oral squamous cell carcinoma via reducing Akt-c-Myc signaling-mediated aerobic glycolysis.
    Li M; Gao F; Zhao Q; Zuo H; Liu W; Li W
    Cell Death Dis; 2020 May; 11(5):381. PubMed ID: 32424132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Butein promotes ubiquitination-mediated survivin degradation inhibits tumor growth and overcomes chemoresistance.
    Dong X; Liu W; Li X; Gan Y; Zhou L; Li W; Xie L
    Sci Rep; 2022 Nov; 12(1):20644. PubMed ID: 36450751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
    Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
    Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumol Exerts Antitumor Effect via Inhibiting EGFR-Akt-Mcl-1 Signaling.
    Li XY; Gao F; Wang XC; Liu LL; Gan Y; Han SZ; Zhou L; Li W; Li M
    Am J Chin Med; 2023; 51(3):741-760. PubMed ID: 36869017
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXM1-Mediated Regulation of Reactive Oxygen Species and Radioresistance in Oral Squamous Cell Carcinoma Cells.
    Takeshita H; Yoshida R; Inoue J; Ishikawa K; Shinohara K; Hirayama M; Oyama T; Kubo R; Yamana K; Nagao Y; Gohara S; Sakata J; Nakashima H; Matsuoka Y; Nakamoto M; Hirayama M; Kawahara K; Takahashi N; Hirosue A; Kuwahara Y; Fukumoto M; Toya R; Murakami R; Nakayama H
    Lab Invest; 2023 May; 103(5):100060. PubMed ID: 36801643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.
    Kunnimalaiyaan S; Trevino J; Tsai S; Gamblin TC; Kunnimalaiyaan M
    Mol Cancer Ther; 2015 Jun; 14(6):1395-403. PubMed ID: 25887885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of multiple pathways involved in the inhibitory effect of HCG22 on oral squamous cell carcinoma progression.
    Wang M; Feng Z; Li X; Sun S; Lu L
    Mol Cell Biochem; 2021 Jun; 476(6):2561-2571. PubMed ID: 33649984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase A inhibition facilitates the antitumor activity of xanthohumol, a valosin-containing protein inhibitor.
    Shikata Y; Yoshimaru T; Komatsu M; Katoh H; Sato R; Kanagaki S; Okazaki Y; Toyokuni S; Tashiro E; Ishikawa S; Katagiri T; Imoto M
    Cancer Sci; 2017 Apr; 108(4):785-794. PubMed ID: 28122154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAICS/DYRK3 Multienzyme Interactions as Coregulators of Purinosome Formation and Metabolism on Radioresistance in Oral Squamous Cell Carcinoma.
    Huang CS; Hsieh MS; Yadav VK; Wu YC; Liu SC; Yeh CT; Huang MS
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survivin silencing enhances radiosensitivity in oral squamous cell carcinoma cell.
    Sun HB; Zheng HY; Yan X
    Eur Rev Med Pharmacol Sci; 2014; 18(18):2678-86. PubMed ID: 25317803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of MET Signaling Mediated by Pitavastatin and Capmatinib Inhibits Oral and Esophageal Cancer Cell Growth.
    Xu B; Muramatsu T; Inazawa J
    Mol Cancer Res; 2021 Apr; 19(4):585-597. PubMed ID: 33443139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
    Chen H; Sa G; Li L; He S; Wu T
    Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ROS/NUPR1-dependent autophagy antagonises repeated cadmium exposure -induced oral squamous cell carcinoma cell migration and invasion.
    Fan T; Chen Y; He Z; Wang Q; Yang X; Ren Z; Zhang S
    Toxicol Lett; 2019 Oct; 314():142-152. PubMed ID: 31319114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer.
    He YF; Liu YP; Liao JZ; Gan Y; Li X; Wang RR; Wang F; Zhou J; Zhou L
    Am J Chin Med; 2024; 52(3):865-884. PubMed ID: 38790085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDK1 Inhibitor BX795 Improves Cisplatin and Radio-Efficacy in Oral Squamous Cell Carcinoma by Downregulating the PDK1/CD47/Akt-Mediated Glycolysis Signaling Pathway.
    Pai S; Yadav VK; Kuo KT; Pikatan NW; Lin CS; Chien MH; Lee WH; Hsiao M; Chiu SC; Yeh CT; Tsai JT
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.